Moas-Héloire Valeria, Renault Nicolas, Batalha Vania, Arias Angela Rincon, Marchivie Mathieu, Yous Said, Deguine Noémie, Buée Luc, Chavatte Philippe, Blum David, Lopes Luisa, Melnyk Patricia, Agouridas Laurence
Université de Lille, F-59000 Lille, France; UDSL, EA 4481, UFR Pharmacie, F-59000 Lille, France.
Instituto de Medecina Molecular, 1640-028, Lisbon, Portugal.
Eur J Med Chem. 2015 Dec 1;106:15-25. doi: 10.1016/j.ejmech.2015.10.030. Epub 2015 Oct 19.
In the aim of identifying new privileged structures, we describe the 5-steps synthesis of cyclic guanidine compounds "tetrahydroisoquinoline-iminoimidazolines" derived from tetrahydroisoquinoline-hydantoin core. In order to evaluate this new minimal structure and the impact of replacing a carbonyle by a guanidine moiety, their affinity towards adenosine receptor A2A was evaluated and compared to those of tetrahydroisoquinoline-hydantoin compounds.
为了鉴定新的优势结构,我们描述了由四氢异喹啉-乙内酰脲核心衍生的环状胍化合物“四氢异喹啉-亚氨基咪唑啉”的五步合成法。为了评估这种新的最小结构以及用胍部分取代羰基的影响,我们评估了它们对腺苷A2A受体的亲和力,并与四氢异喹啉-乙内酰脲化合物的亲和力进行了比较。